[] Corporate [] Research [] Genzyme Websites
Patients Healthcare Professionals  
Uncomplicating the futureSM
 
Search

Healthcare Professionals

Applying SEPRAFILM
Healthcare Professionals: Home > Applying SEPRAFILM     Print page  

Applying SEPRAFILM®

The videos on the right and illustrations below (click here for a PDF of the illustrations below) demonstrate common application techniques that may help you in using SEPRAFILM Adhesion Barrier. In addition, remember the following tips:

  • For easy application, always use dry gloves or a dry sponge on a sponge stick
  • To ensure adequate coverage, overlap multiple sheets and apply sufficiently beyond the margins of surgical trauma
  • If SEPRAFILM has not completely adhered, use a dry sponge on a sponge stick to pat down SEPRAFILM and lightly moisten SEPRAFILM with standard irrigation solution
  • Once deployed on tissue, you may wet SEPRAFILM with saline to accelerate adherence to tissue and allow for adjacent tissue to slide against the film. This technique also allows for the use of a malleable retractor or FISH with minimal sticking to SEPRAFILM.

"Taco" technique

"taco" technique


"Quilting" technique

"quilt" technique

Download our list of Frequently Asked Questions about applying SEPRAFILM, or ask your sales representative for additional application techniques.


 
SEPRAFILM Application in Obstetrics

SEPRAFILM Application in Gynecologic Procedures

SEPRAFILM Application in Abdominal and Colorectal Procedures

SEPRAFILM Basics: General Application and How it Works

 

Indication

Seprafilm® Adhesion Barrier is indicated for the reduction of post-surgical adhesions in patients undergoing abdominal or pelvic laparotomy.

Important Safety Information

Seprafilm should not be wrapped around an intestinal anastomosis as such usage may result in increased anastomotic leak related events, such as abscess or peritonitis. The safety and effectiveness of Seprafilm has not been established in combination with other adhesion prevention products and/or in surgical procedures not within the abdominopelvic cavity. The safety and effectiveness of Seprafilm has also not been evaluated in cases of pregnancy, malignancy, or frank infection. The type and frequency of adverse events reported are consistent with events typically seen following abdominopelvic surgery when used as directed.

Please see full prescribing information.

Terms and Conditions of Use | Privacy Policy | Contact Us | This site is intended for United States residents only © 2002-2012 Genzyme Corporation. All rights reserved. Seprafilm and Genzyme are registered trademarks of Genzyme Corporation. genzyme logo